ClinicalTrials.gg
RecruitingNCT07007598PiCAntUpdated Jun 18, 2025

Prevention of Post-Polypectomy Colorectal Bleeding by Clips in Patients on Anticoagulants

An observational study in Polyp of Colon, sponsored by Helios Kliniken Schwerin. Recruiting at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-06-18.

Sponsored by Helios Kliniken Schwerin · Observational

From the registry’s dates

  • Primary completion was expected by May 2026, 6 months ago, but the record still lists the study as recruiting.
  • Started May 2025; still recruiting 1 year 6 months later.
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
10,000
Ages
18 Years and older
Sex
All
01

Study summary

This observational study aims to retrospectively determine if clips can prevent post-polypectomy bleeding in adults who have received restarted anticoagulants after a colorectal polypectomy, using a large, single-center patient registry.

The main question it aims to answer is:

Can clips prevent post-polypectomy bleeding in adults who have received restarted anticoagulants after a colorectal polypectomy? Researchers will compare adults who received preventive clipping after a polypectomy with those who did not, regarding colorectal bleeding after receiving restarted anticoagulants.

Participants have undergone a colorectal polypectomy and received restarted anticoagulants (acetylsalicylic acid excluded) after the procedure.

Read the detailed description

Screening colonoscopy allows early detection of cancer and removal of adenomas before they become malignant. Unresected polyps larger than 1 cm have a 24% risk of invasive adenocarcinoma. Post-polypectomy bleeding is influenced by factors such as polyp size, location, tumor type, anticoagulants and concomitant diseases. Prophylactic measures such as clipping show mixed results; selective clipping is cost-effective, but universal clipping is not. The updated ESGE guideline on colorectal polypectomy and endoscopic mucosal resection from 2024 recommends prophylactic endoscopic clip of the mucosal defect after endoscopic mucosal resection of large non-pedunculated polyps in the right colon to reduce the risk of delayed bleeding. However, there is no clear recommendation for patients on anticoagulants whether to use or not to use prophylactic clipping. Therefore, this observational study aims to retrospectively determine if clips can prevent post-polypectomy bleeding in adults who have received restarted anticoagulants after a colorectal polypectomy, using a large, single-center patient registry (> 10.000 colonoscopies).

02

Conditions studied

  • Polyp of Colon

Keywords

  • polyps
  • Hemorrhage
  • Anticoagulants
03

In context

Colonic Polyps

377 studies on the registry are indexed under Colonic Polyps; 57 are open to participants now.

This study's planned enrollment of 10,000 is above the median of 411 across 115 observational studies indexed under Colonic Polyps.

Browse Colonic Polyps studies →

Lead sponsor

Helios Kliniken Schwerin is the lead sponsor of 2 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Adults who have received an endoscopic colorectal polypectomy

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • adult who has received a colonoscopy with endoscopic colorectal polypectomy
  • patient who has received at least one anticoagulant after polypectomy

Exclusion criteria

Exclusion Criteria:

  • Endoscopic polypectomy was combined with closure of the mucosal defect by a suturing device or full thickness resection device
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
10,000 participants (estimated)
Target follow-up
30 Days
Patient registry
Yes

Groups and cohorts

  • Colorectal polypectomy and prophylactic clipping before restarted anticoagulants

    At least one prophylactic clip is applied to close the mucosal defect after polypectomy

    Device: Hemostatic clip

  • Colorectal polypectomy without prophylactic clipping before restarted anticoagulant

    A prophylactic clip is not applied to close the mucosal defect after polypectomy.

Interventions

  • DeviceHemostatic clip

    The hemostatic clip is endoscopically applied after a colorectal polypectomy to close the mucosal defect.

06

What researchers measure

Primary outcomes

  1. Colorectal Post-polypectomy bleeding

    Mucosal defect-associated bleeding after removal of a colorectal polyp bei endoscopic polypectomy. The metachronous interval bleeding rate is calculated by dividing the number of bleeding events by the number of colonoscopies with polypectomy. The following are counted as polypectomy bleeding: 1. Polypectomy bleeding is visualized directly during a subsequent colonoscopy. 2. Polypectomy bleeding is considered probable if a subsequent colonoscopy is performed due to lower gastrointestinal bleeding, and evidence of blood is found in association with the polypectomy. 3. Polypectomy bleeding is considered probable if the patient was hospitalized for monitoring or had his hospital stay extended because he showed visible perianal bleeding. However, a colonoscopy was not performed because the bleeding had stopped spontaneously and/or the risk of a subsequent colonoscopy was deemed too high in relation to the potential benefits.

    Time frame: Up to 30 days after colorectal endoscopic polypectomy

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Nishad N, Thoufeeq MH. Post-polypectomy colorectal bleeding: current strategies and the way forward. Clin Endosc. 2025 Mar;58(2):191-200. doi: 10.5946/ce.2024.241. Epub 2024 Nov 27. PubMed 39722137 ↗
  • Ferlitsch M, Hassan C, Bisschops R, Bhandari P, Dinis-Ribeiro M, Risio M, Paspatis GA, Moss A, Libanio D, Lorenzo-Zuniga V, Voiosu AM, Rutter MD, Pellise M, Moons LMG, Probst A, Awadie H, Amato A, Takeuchi Y, Repici A, Rahmi G, Koecklin HU, Albeniz E, Rockenbauer LM, Waldmann E, Messmann H, Triantafyllou K, Jover R, Gralnek IM, Dekker E, Bourke MJ. Colorectal polypectomy and endoscopic mucosal resection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2024. Endoscopy. 2024 Jul;56(7):516-545. doi: 10.1055/a-2304-3219. Epub 2024 Apr 26. PubMed 38670139 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2025 (actual). Primary completion is estimated for May 2026, 12 months after the start.

Of 52 non-industry observational studies under Colonic Polyps, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 90. This study's planned 12 months is below that.

Counting every sponsor, half of 62 studies reached it within 19 months; a quarter within 10 and three quarters within 90.

How these figures are worked out, and which studies are left out of them.

Registered
May 28, 2025
First posted
Jun 6, 2025
StartActual
May 1, 2025
Primary completionEst.
May 1, 2026
CompletionEst.
Nov 1, 2026
Last update
Jun 18, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 18, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07007598
Lead sponsor
Helios Kliniken Schwerin
Collaborators
Medical School Hamburg
Responsible party
Dr. med. Daniel Schmitz (Head Physician, Helios Kliniken Schwerin) — Principal investigator
First posted
Jun 6, 2025
Start date
May 1, 2025
Primary completion
May 1, 2026 (estimated)
Completion
Nov 1, 2026 (estimated)
Last update
Jun 18, 2025

Study contacts

Daniel Schmitz, Dr. med.
Contact
Daniel.Schmitz@helios-gesundheit.de
+493855202601
Martin Kliment
Contact
Martin.Kliment@helios-gesundheit.de
+493855202601
Daniel Schmitz, Dr.med.
principal investigator · Helios Kliniken Schwerin

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion